$STVN News

Stevanato Group S.p.A. (STVN) Rallies on 2Q26 Revenue Growth and EBITDA Margin Expansion

Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection

Aptar Pharma and Stevanato Group Collaborate to Help Accelerate Pre-Filled Syringe System Selection

Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026

Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

UBS Maintains Neutral on Stevanato Group, Lowers Price Target to $23

Stevanato Group to Participate in Two Upcoming Investor Conferences

Stevanato Group (STVN) Trades A Subsidiary For Margin Gains And Growth

Riverwater Sees a Market Overreaction in Stevanato Group (STVN) After Oral GLP-1 Launches

Stevanato Group: Alina Validates The Container-To-Device Flywheel

Chief Financial Officer At Stevanato Group Sells $84K Of Stock

Stevanato Group (STVN) Could Be 16% Undervalued Following Earnings And Guidance Update

How Investors Are Reacting To Stevanato Group (STVN) Trimmed Guidance And New GLP-1 Pen Approvals

Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings

Stevanato Group Q2 Earnings Call Highlights

Is Stevanato (STVN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Stevanato (STVN) Q2 2026 Earnings Call Transcript

Stevanato Group S.p.A. Q2 2026 Earnings Call Summary

Stevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ...

Stevanato Group S.p.A. (STVN) Q2 2026 Earnings Call Transcript